There has been an unprecedented and very suspect campaign against the use of Hydroxychloroquine (HCQ) to treat Covid-19.
False Information Published by The Lancet
From the article:
The world was stunned when The Lancet, medicine’s most respected scientific journal, retracted a blockbuster article within two weeks of its publication over data credibility.
The public, alarmed by a retraction about COVID-19 treatment from the world’s most stringent standard in scientific publication, coined it “Lancet-gate”.
The retracted article [falsely] reported a chilling mortality risk among COVID-19 patients treated with anti-malarial drugs chloroquine (CQ) or hydroxychloroquine (HCQ). The article made many believe the drugs might have caused more deaths than cures.
The public, alarmed by a retraction about COVID-19 treatment from the world’s most stringent standard in scientific publication, coined it “Lancet-gate”.
The retracted article [falsely] reported a chilling mortality risk among COVID-19 patients treated with anti-malarial drugs chloroquine (CQ) or hydroxychloroquine (HCQ). The article made many believe the drugs might have caused more deaths than cures.
Articles
From the article:
What President Trump called a potential “game-changer” in the battle against COVID-19—a safe, cheap, effective treatment, available NOW—is suddenly seen as a highly dangerous drug. Of the fake news and misinformation that has proliferated in this pandemic, the most harmful is the claim that hydroxychloroquine (HCQ) is a serious heart hazard. That incorrect claim has been supported by prestigious medical journals.
This negative message contradicts 65 years of experience of safe, worldwide use of HCQ for malaria, lupus, and rheumatoid arthritis. Hundreds of millions of patients have taken it without difficulty and without serious side effects. Recent studies in several countries have shown that if used early, within the first week of symptoms, HCQ is safe and highly effective for COVID-19.
This negative message contradicts 65 years of experience of safe, worldwide use of HCQ for malaria, lupus, and rheumatoid arthritis. Hundreds of millions of patients have taken it without difficulty and without serious side effects. Recent studies in several countries have shown that if used early, within the first week of symptoms, HCQ is safe and highly effective for COVID-19.
Yet the Food and Drug Administration is severely restricting its use to hospitalized patients, and doing nothing to counter the fearmongering.
Comments